FR2395753A1 - Composition pharmaceutique a base de certains acides phenylglyoxyliques ou de leurs derives - Google Patents

Composition pharmaceutique a base de certains acides phenylglyoxyliques ou de leurs derives

Info

Publication number
FR2395753A1
FR2395753A1 FR7819488A FR7819488A FR2395753A1 FR 2395753 A1 FR2395753 A1 FR 2395753A1 FR 7819488 A FR7819488 A FR 7819488A FR 7819488 A FR7819488 A FR 7819488A FR 2395753 A1 FR2395753 A1 FR 2395753A1
Authority
FR
France
Prior art keywords
certain
derivatives
pharmaceutical composition
composition based
phenylglyoxylic acids
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7819488A
Other languages
English (en)
Other versions
FR2395753B1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Corp
Original Assignee
Pfizer Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Corp filed Critical Pfizer Corp
Publication of FR2395753A1 publication Critical patent/FR2395753A1/fr
Application granted granted Critical
Publication of FR2395753B1 publication Critical patent/FR2395753B1/fr
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40—Unsaturated compounds
    • C07C59/76—Unsaturated compounds containing keto groups
    • C07C59/84—Unsaturated compounds containing keto groups containing six membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40—Unsaturated compounds
    • C07C59/76—Unsaturated compounds containing keto groups
    • C07C59/88—Unsaturated compounds containing keto groups containing halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40—Unsaturated compounds
    • C07C59/76—Unsaturated compounds containing keto groups
    • C07C59/90—Unsaturated compounds containing keto groups containing singly bound oxygen-containing groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

L'invention a trait au domaine de la pharmacie. Elle contient une composition contenant certains acides phénylglyoxyliques, leurs esters ou leurs sels. La composition de l'invention est destinée au traitement de maladies et d'états se caractérisant par une réduction du débit sanguin, de la disponibilité en oxygene ou du métabolisme des glucides dans le système cardiovasculaire ou d'autres maladies impliquant des anomalies du métabolisme des glucides, par exemple l'obésité et le diabète.
FR7819488A 1977-07-01 1978-06-29 Composition pharmaceutique a base de certains acides phenylglyoxyliques ou de leurs derives Granted FR2395753A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB2775677 1977-07-01

Publications (2)

Publication Number Publication Date
FR2395753A1 true FR2395753A1 (fr) 1979-01-26
FR2395753B1 FR2395753B1 (fr) 1982-11-12

Family

ID=10264753

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7819488A Granted FR2395753A1 (fr) 1977-07-01 1978-06-29 Composition pharmaceutique a base de certains acides phenylglyoxyliques ou de leurs derives

Country Status (17)

Country Link
US (1) US4219566A (fr)
JP (1) JPS5414522A (fr)
AU (1) AU507286B1 (fr)
BE (1) BE868665A (fr)
CA (1) CA1118353A (fr)
DE (1) DE2828620C2 (fr)
FR (1) FR2395753A1 (fr)
GB (1) GB2000441B (fr)
GR (1) GR70238B (fr)
IE (1) IE47713B1 (fr)
IL (1) IL55040A0 (fr)
IT (1) IT1096860B (fr)
LU (1) LU79902A1 (fr)
NL (1) NL175030C (fr)
PT (1) PT68239A (fr)
SE (1) SE7806692L (fr)
ZA (1) ZA783746B (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60237968A (ja) * 1985-03-08 1985-11-26 Kibun Kk 繊維集合状練製品

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2868836A (en) * 1956-04-19 1959-01-13 Merck & Co Inc 2, 4-dihydroxy-3-methylphenylglyoxylic acid and derivatives thereof

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE949521C (de) * 1955-01-09 1956-09-20 Merck Ag E Lichtschutzmittel
US3532737A (en) * 1967-02-02 1970-10-06 Sterling Drug Inc Esters of arylglyoxylic acids
US3754006A (en) * 1967-02-02 1973-08-21 Sterling Drug Inc Esters and amides of substituted glyoxylic acids
US3830930A (en) * 1969-05-14 1974-08-20 Nickstadt Moeller Inc Labial compositions containing menthyl keto esters
US3657325A (en) * 1969-12-03 1972-04-18 Sterling Drug Inc Esters of substituted glyoxylic acids
US3818072A (en) * 1971-12-01 1974-06-18 Richardson Merrell Inc Alkyl substituted-benzoylacetates antilipemic agents
US3898269A (en) * 1972-07-03 1975-08-05 Rorer Inc William H Tetrahydronaphthylglyoxylic acids and esters
DE2335215B2 (de) * 1972-07-13 1979-04-05 The Johns Hopkins University, Baltimore, Md. (V.St.A.) Verwendung einer Mischung bei der Bekämpfung von zur Urämie führenden Nierenerkrankungen

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2868836A (en) * 1956-04-19 1959-01-13 Merck & Co Inc 2, 4-dihydroxy-3-methylphenylglyoxylic acid and derivatives thereof

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
EXBK/1964 *

Also Published As

Publication number Publication date
IL55040A0 (en) 1978-08-31
US4219566A (en) 1980-08-26
PT68239A (en) 1978-06-30
JPS5414522A (en) 1979-02-02
IT1096860B (it) 1985-08-26
SE7806692L (sv) 1979-01-02
ZA783746B (en) 1979-07-25
IE781321L (en) 1979-01-01
DE2828620C2 (de) 1982-04-01
GB2000441B (en) 1982-01-06
BE868665A (fr) 1979-01-02
DE2828620A1 (de) 1979-02-01
CA1118353A (fr) 1982-02-16
GB2000441A (en) 1979-01-10
IT7825152A0 (it) 1978-06-29
NL175030C (nl) 1984-09-17
GR70238B (fr) 1982-09-01
NL175030B (nl) 1984-04-16
AU507286B1 (en) 1980-02-07
IE47713B1 (en) 1984-05-30
LU79902A1 (fr) 1980-01-22
FR2395753B1 (fr) 1982-11-12
NL7807091A (nl) 1979-01-03

Similar Documents

Publication Publication Date Title
Engel et al. Lipid storage myopathy responsive to prednisone
Brevetti et al. Increases in walking distance in patients with peripheral vascular disease treated with L-carnitine: a double-blind, cross-over study.
Summaria et al. The specific mechanism of activation of human plasminogen to plasmin
Boyd et al. The effect of certain thyroxine analogues on the serum lipids in human subjects
JPS62267222A (ja) 不飽和脂肪酸含有製剤
BE904476A (fr) Solutions a base de phenytoine, leur procede de preparation et leur application pharmaceutique.
BE901210A (fr) Nouveaux retinoides.
Preiser et al. Metabolic Effects of Arginine Addition to the Enteral Feeding of Critically III Patients
FR2395753A1 (fr) Composition pharmaceutique a base de certains acides phenylglyoxyliques ou de leurs derives
Norum et al. The effect of plasma transfusion on the plasma cholesterol esters in patients with familial plasma lecithin: cholesterol acyltransferase deficiency
DOWLING et al. Abnormal iodoproteins in the blood of eumetabolic goitrous adults
Tishkoff et al. Excretion of δ-aminolevulinic acid in lead intoxication
Winberg et al. Cortisone Treatment in Vitamin D Intoxication 1
Takimoto et al. Plasma fibrinolytic activity after ingestion of omega-3 fatty acids in human subjects
FR2365340A1 (fr) Composition pharmaceutique contenant des phenylglycines l ou dl (racemiques)
Sánchez-Romero et al. Effect of fish oil on oxidative stress markers in patients with probable Alzheimer's disease
RAWSON Today's thyroidologists and their beckoning frontiers
McDermott The role of ammonia intoxication in hepatic coma
Elattar et al. The Effect of Non-steroidal Anti-inflammatory Drugs on the Metabolism of C-Arachidonic Acid by Human Gingival Tissue in vitro
Leonardi et al. Prevention of aspirin inhibition of platelet release reaction by the fatty acid precursor of platelet prostaglandins
Morris et al. Rifabutin-induced ageusia
JP3421081B2 (ja) Ｌ−カルニチンの測定方法及び測定装置
Mehler et al. Biological reactions of fluoroacetylcholine
Ueland et al. Total homocysteine is making its way into pediatric laboratory diagnostics
Poley et al. Alterations in the concentration of cholesterol in bile after administration of human growth hormone

Legal Events

Date Code Title Description
ST Notification of lapse